Get started
Author

Galina Repik

Observed name: Galina Repik (1864693)
OpenAlex ID: A5037497696
Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)
2013 · Edward J. Hennessy, Ammar Adam, et al. · Journal of Medicinal Chemistry · 120
Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling
2003 · Frantisek Sandor, Eicke Latz, et al. · The Journal of Cell Biology · 114
3-Amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor
2011 · David A. Scott, Les A. Dakin, et al. · Bioorganic & Medicinal Chemistry Letters · 46
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507
2013 · David A. Scott, Les A. Dakin, et al. · Bioorganic & Medicinal Chemistry Letters · 32
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors
2014 · Jeffrey G. Varnes, Thomas Gero, et al. · Bioorganic & Medicinal Chemistry Letters · 18
Abstract B100: Structure-based design of AZ7732 a novel in vivo active beta-alanine-derived pan-IAP inhibitor.
2013 · Jamal C. Saeh, Brian Aquila, et al. · Molecular Cancer Therapeutics
Abstract 2011: A novel bcl-2/xL inhibitor induces tumor cell apoptosis and potentiates the activity of standard chemotherapeutics
2012 · Terry MacIntyre, Francoise Powell, et al. · Cancer Research
Works count: 8
Citation count: 330
H-index: 5
I10-index: 5
Year
Topic
Type